ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.33
0.42%
US Tech 100
21,151.60
0.76%
S&P 500
6,049.24
0.88%
US Dollar vs CAD
1.43343
-0.07%
Bitcoin
104,826.11
-1.27%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Hepion Pharmaceuticals Inc (HEPA)

  7. Hepion Pharmaceuticals Inc (HEPA) News

HEPA

Hepion Pharmaceuticals (HEPA)

Hepion Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:HEPA
DateTimeSourceHeadlineSymbolCompany
01/13/20256:00AMEdgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:HEPAHepion Pharmaceuticals Inc
12/11/20247:26AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HEPAHepion Pharmaceuticals Inc
12/11/20247:00AMGlobeNewswire Inc.Hepion Pharmaceuticals, Inc. Announces Termination of Merger Agreement with Pharma Two B Ltd.NASDAQ:HEPAHepion Pharmaceuticals Inc
12/05/20247:48AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:HEPAHepion Pharmaceuticals Inc
12/02/20247:53AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:HEPAHepion Pharmaceuticals Inc
12/02/20247:00AMGlobeNewswire Inc.Hepion Pharmaceuticals Issues Letter to Shareholders Urging Support for Proposed Merger with Pharma Two BNASDAQ:HEPAHepion Pharmaceuticals Inc
11/21/20244:01PMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:HEPAHepion Pharmaceuticals Inc
11/21/20244:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HEPAHepion Pharmaceuticals Inc
11/11/20247:00AMGlobeNewswire Inc.Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Effectiveness of Registration Statement Related to Proposed MergerNASDAQ:HEPAHepion Pharmaceuticals Inc
09/04/20248:25AMGlobeNewswire Inc.Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Filing of Registration Statement on Form F-4 Related to Proposed MergerNASDAQ:HEPAHepion Pharmaceuticals Inc
08/07/20248:08AMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:HEPAHepion Pharmaceuticals Inc
08/07/20248:04AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HEPAHepion Pharmaceuticals Inc
07/22/20247:00AMGlobeNewswire Inc.Pharma Two B Announces Plans to Go Public via Merger with Hepion Pharmaceuticals, Inc. and Concurrent $11.5 Million Private PlacementNASDAQ:HEPAHepion Pharmaceuticals Inc
05/21/20244:08PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HEPAHepion Pharmaceuticals Inc
05/15/20243:46PMEdgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:HEPAHepion Pharmaceuticals Inc
04/19/20243:30PMGlobeNewswire Inc.Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b ‘ASCEND-NASH’ TrialNASDAQ:HEPAHepion Pharmaceuticals Inc
02/16/20248:02AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HEPAHepion Pharmaceuticals Inc
02/16/20247:00AMGlobeNewswire Inc.Hepion Pharmaceuticals Announces Exercise of Warrants for Approximately $2.0 Million Aggregate Gross ProceedsNASDAQ:HEPAHepion Pharmaceuticals Inc
02/14/20242:38PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:HEPAHepion Pharmaceuticals Inc
01/03/20244:15PMGlobeNewswire Inc.Hepion Pharmaceuticals to Present at NASH-TAG 2024NASDAQ:HEPAHepion Pharmaceuticals Inc
01/03/20243:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HEPAHepion Pharmaceuticals Inc
12/07/20237:00AMGlobeNewswire Inc.Hepion Pharmaceuticals Announces Restructuring Plan to Enhance Shareholder Value and Management ChangesNASDAQ:HEPAHepion Pharmaceuticals Inc
11/28/20233:15PMGlobeNewswire Inc.Hepion Pharmaceuticals to Present at the 7th Obesity & NASH Drug Development SummitNASDAQ:HEPAHepion Pharmaceuticals Inc
11/13/20233:05PMGlobeNewswire Inc.Hepion Pharmaceuticals Announces Major Reductions in Liver Stiffness with Rencofilstat Treatment in 17-week Phase 2 Study of Advanced (F3) MASH Liver DiseaseNASDAQ:HEPAHepion Pharmaceuticals Inc
11/10/20237:50AMGlobeNewswire Inc.Hepion Pharmaceuticals Schedules Conference Call to Review Additional Efficacy Data from Phase 2 ‘ALTITUDE-NASH’ Liver Function Trial of RencofilstatNASDAQ:HEPAHepion Pharmaceuticals Inc
11/08/202311:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:HEPAHepion Pharmaceuticals Inc
10/25/20237:30AMGlobeNewswire Inc.Hepion Pharmaceuticals’ Rencofilstat Demonstrates Anti-Cancer Activity in Hepatitis C-Associated Cancer ModelNASDAQ:HEPAHepion Pharmaceuticals Inc
09/29/20237:00AMGlobeNewswire Inc.Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq RulesNASDAQ:HEPAHepion Pharmaceuticals Inc
09/21/20233:05PMGlobeNewswire Inc.Hepion Pharmaceuticals to Participate in 2023 Cantor Global Healthcare ConferenceNASDAQ:HEPAHepion Pharmaceuticals Inc
09/21/20237:00AMGlobeNewswire Inc.New Anti-Cancer Opportunities Revealed for Hepion Pharmaceuticals’ Rencofilstat in Cancer Screening ProgramNASDAQ:HEPAHepion Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:HEPA

Your Recent History

USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
HIRU
Hiru (PK)
USOTC
TPTW
TPT Global Tech (CE)
AMEX
KULR
KULR Technology
USOTC
PHIL
PHI (PK)
USOTC
AXXA
Exxe (PK)
USOTC
NBRI
North Bay Resources (PK)
USOTC
CNNA
Cann American (CE)
USOTC
CGAC
Code Green Apparel (PK)
NASDAQ
ILLR
Triller
USOTC
ASII
Accredited Solutions (PK)
USOTC
AABB
Asia Broadband (PK)
USOTC
FDCT
FDCTech (PK)
USOTC
TGLO
TheGlobe com (PK)
NASDAQ
FCEL
FuelCell Energy
NYSE
AMC
AMC Entertainment
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads